World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12614001016628
Date of registration: 22/09/2014
Prospective Registration: No
Primary sponsor: Combined military hospital, Panoaqil cantt
Public title: The Effects Of Intraarticular Platelet Rich Plasma versus Steroid Injection In Meniscal Injuries- A Randomized Controlled Trial
Scientific title: A randomised controlled trial to evaluate the effect of intraarticular platelet rich plasma injection versus intraarticular triamcinolone acetonide injection on pain relief and functional outcomes in adult males with meniscal injuries
Date of first enrolment: 07/07/2014
Target sample size: 30
Recruitment status: Recruiting
URL:  https://anzctr.org.au/ACTRN12614001016628.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;  
Phase:  Phase 2
Countries of recruitment
Pakistan
Contacts
Name: Dr Sarah Razaq   
Address:  Major Sarah Razaq, classified rehab specialist, Rehab department, Combined Military Hospital, Panoaqil cantt (65120), distt Sukkur, Sindh, Pakistan Pakistan
Telephone: +923336123022
Email: docsr@hotmail.com
Affiliation: 
Name: Dr Sarah Razaq   
Address:  Major Sarah Razaq, classified rehab specialist, Rehab department, Combined Military Hospital, Panoaqil cantt (65120), distt Sukkur, Sindh, Pakistan Pakistan
Telephone: +923336123022
Email: docsr@hotmail.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Age more than 18 yrs,
knee pain lasting more than 3 months,
History of twisting injury to knee,
Clinical and MRI evidence of meniscal injuries

Exclusion criteria: Other Intraarticular knee injections in last 3 months

Age minimum: 18 Years
Age maximum: 40 Years
Gender: Males
Health Condition(s) or Problem(s) studied
Meniscal injuries;
Meniscal injuries
Musculoskeletal - Other muscular and skeletal disorders
Intervention(s)
Two intraarticular knee injection of 3 ml of platelet rich plasma will be given 2 weeks apart in total. Platelet rich plasma will be obtained from patient's own blood. 30 ml of venous blood will be taken from the patient, which will yield 3 ml of Platelet rich plasma.
Primary Outcome(s)
Knee pain will be assessed using Visual analogue scale (VAS)[At baseline, 4 and 12 weeks ater intervention]
Secondary Outcome(s)
Adverse events including: 1. Increase in pain
2. Swelling
3. Difficulty in walking[0,4 12 weeks]
Knee injury and osteoarthritis outcome score (KOOS) will be used to assess the knee function, symptomatic improvement, pain, stiffness in knee, [At baseline, 4 and 12 weeks ater intervention]
patient satisfaction in YES/NO[0,4, 12 weeks]
Secondary ID(s)
nil
Source(s) of Monetary Support
Combined Military Hospital, Panoaqil
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
CMH Panoaqil ethics committee
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history